Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Reinstadler, M. Reindl, H. Feistritzer, G. Klug, A. Mayr, M. Kofler, A. Tu, L. Huybrechts, J. Mair, W. Franz, B. Metzler (2015)
Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance studyWiener klinische Wochenschrift, 127
H. Thiele, J. Wöhrle, P. Neuhaus, O. Brosteanu, P. Sick, R. Prondzinsky, R. Birkemeyer, M. Wiemer, S. Kerber, H. Schuehlen, Klaus Kleinertz, C. Axthelm, R. Zimmermann, H. Rittger, R. Braun-Dullaeus, B. Lauer, Wolfgang Burckhardt, M. Ferrari, M. Bergmann, R. Hambrecht, G. Schuler (2010)
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial.American heart journal, 159 4
J. Goldberger, R. Arora, D. Green, P. Greenland, Daniel Lee, D. Lloyd‐Jones, M. Markl, J. Ng, Sanjiv Shah (2015)
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic SubstrateCirculation, 132
S. Parashar, Danesh Kella, K. Reid, J. Spertus, F. Tang, J. Langberg, V. Vaccarino, M. Kontos, R. Lopes, M. Lloyd (2013)
New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).The American journal of cardiology, 112 9
I. Eitel, S. Desch, S. Waha, G. Fuernau, M. Gutberlet, G. Schuler, H. Thiele (2011)
Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarctionJournal of Cardiovascular Magnetic Resonance, 13
M. Reindl, S. Reinstadler, H. Feistritzer, C. Tiller, A. Mayr, G. Klug, B. Metzler (2016)
Heart rate and left ventricular adverse remodelling after ST-elevation myocardial infarction.International journal of cardiology, 219
P. Gal, E. Parlak, D. Schellings, R. Beukema, J. Berg, A. Adiyaman, A. Hof, A. Elvan (2016)
Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary interventionEuropean Heart Journal: Acute Cardiovascular Care, 5
M. Lamberts, J. Olesen, M. Ruwald, C. Hansen, D. Karasoy, S. Kristensen, L. Køber, C. Torp-Pedersen, G. Gislason, M. Hansen (2012)
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort StudyCirculation, 126
P. Jabre, V. Roger, M. Murad, A. Chamberlain, L. Prokop, F. Adnet, X. Jouven (2011)
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-AnalysisCirculation, 123
S. Reinstadler, H. Feistritzer, G. Klug, J. Mair, A. Tu, M. Kofler, B. Henninger, W. Franz, B. Metzler (2016)
High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.International journal of cardiology, 202
Mohammadali Habibi, S. Samiei, B. Venkatesh, A. Opdahl, T. Helle-Valle, Mytra Zareian, A. Almeida, E. Choi, C. Wu, Á. Alonso, S. Heckbert, D. Bluemke, J. Lima (2016)
Cardiac Magnetic Resonance–Measured Left Atrial Volume and Function and Incident Atrial Fibrillation: Results From MESA (Multi-Ethnic Study of Atherosclerosis)Circulation: Cardiovascular Imaging, 9
Amartya Kundu, Kevin O’Day, Amir Shaikh, D. Lessard, J. Saczynski, J. Yarzebski, C. Darling, Ramses Thabet, M. Akhter, K. Floyd, R. Goldberg, D. McManus (2016)
Relation of Atrial Fibrillation in Acute Myocardial Infarction to In-Hospital Complications and Early Hospital Readmission.The American journal of cardiology, 117 8
L. Bengtson, L. Chen, A. Chamberlain, E. Michos, E. Whitsel, P. Lutsey, S. Duval, W. Rosamond, Á. Alonso (2014)
Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study).The American journal of cardiology, 114 5
S. Reinstadler, C. Eitel, Merle Thieme, B. Metzler, J. Poess, S. Desch, H. Thiele, I. Eitel (2016)
Comparison of Characteristics of Patients aged ≤45 Years Versus >45 Years With ST-Elevation Myocardial Infarction (from the AIDA STEMI CMR Substudy).The American journal of cardiology, 117 9
S. Desch, H. Engelhardt, Josefine Meissner, I. Eitel, M. Sareban, G. Fuernau, S. Waha, M. Grothoff, M. Gutberlet, G. Schuler, H. Thiele (2012)
Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarctionThe International Journal of Cardiovascular Imaging, 28
I. Eitel, S. Waha, J. Wöhrle, G. Fuernau, P. Lurz, M. Pauschinger, S. Desch, G. Schuler, H. Thiele (2014)
Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction.Journal of the American College of Cardiology, 64 12
D. Morrow, E. Antman, A. Charlesworth, Richard Cairns, S. Murphy, J. Lemos, R. Giugliano, C. Mccabe, E. Braunwald (2000)
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial SubstudyCirculation: Journal of the American Heart Association, 102
J. Schmitt, G. Duray, B. Gersh, S. Hohnloser (2009)
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.European heart journal, 30 9
A. Huber, J. Lamy, Amer Rahhal, M. Evin, F. Atassi, C. Defrance, G. Lebreton, K. Clément, M. Berthet, R. Isnard, P. Leprince, P. Cluzel, S. Hatem, N. Kachenoura, A. Redheuil (2018)
Cardiac MR Strain: A Noninvasive Biomarker of Fibrofatty Remodeling of the Left Atrial Myocardium.Radiology, 286 1
H. Hod, A. Lew, M. Keltai, B. Cercek, I. Geft, P. Shah, W. Ganz (1987)
Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion.Circulation, 75 1
J. Oldgren, Z. Hijazi, J. Lindbäck, J. Alexander, S. Connolly, J. Eikelboom, M. Ezekowitz, C. Granger, E. Hylek, R. Lopes, A. Siegbahn, S. Yusuf, L. Wallentin (2016)
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationCirculation, 134
S. Buuren, K. Groothuis-Oudshoorn (2011)
MICE: Multivariate Imputation by Chained Equations in RJournal of Statistical Software, 45
R. Tibshirani (1997)
The lasso method for variable selection in the Cox model.Statistics in medicine, 16 4
J. Lønborg, Thomas Engstrøm, J. Møller, K. Ahtarovski, H. Kelbæk, L. Holmvang, E. Jørgensen, S. Helqvist, K. Saunamäki, H. Søholm, Mads Andersen, A. Mathiasen, J. Kühl, P. Clemmensen, L. Køber, Niels Vejlstrup (2013)
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study.European heart journal cardiovascular Imaging, 14 2
L. Staerk, Jason Sherer, D. Ko, E. Benjamin, Robert Helm (2017)
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical OutcomesCirculation Research, 120
J. Wi, D. Shin, Jung‐Sun Kim, Byeong‐Keuk Kim, Y. Ko, D. Choi, M. Hong, Y. Jang (2016)
Transient New-Onset Atrial Fibrillation Is Associated With Poor Clinical Outcomes in Patients With Acute Myocardial Infarction.Circulation journal : official journal of the Japanese Circulation Society, 80 7
K. Eagle, M. Lim, O. Dabbous, K. Pieper, R. Goldberg, F. Werf, S. Goodman, C. Granger, P. Steg, J. Gore, A. Budaj, Á. Avezum, M. Flather, K. Fox, Grace Investigators (2004)
A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registryJAMA, 291
A. Halkin, Mandeep Singh, E. Nikolsky, C. Grines, J. Tcheng, Eulogio García, D. Cox, M. Turco, T. Stuckey, Yingo Na, A. Lansky, B. Gersh, W. O’Neill, R. Mehran, G. Stone (2005)
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.Journal of the American College of Cardiology, 45 9
G. Captur, C. Manisty, J. Moon (2016)
Cardiac MRI evaluation of myocardial diseaseHeart, 102
H. Thiele, J. Wöhrle, R. Hambrecht, H. Rittger, R. Birkemeyer, B. Lauer, P. Neuhaus, O. Brosteanu, P. Sick, M. Wiemer, S. Kerber, Klaus Kleinertz, I. Eitel, S. Desch, G. Schuler (2012)
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trialThe Lancet, 379
Z. Hijazi, J. Oldgren, U. Andersson, S. Connolly, M. Ezekowitz, S. Hohnloser, P. Reilly, D. Vinereanu, A. Siegbahn, S. Yusuf, L. Wallentin (2012)
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) SubstudyCirculation, 125
Y. Miyasaka, M. Barnes, B. Gersh, S. Cha, K. Bailey, W. Abhayaratna, J. Seward, T. Tsang (2006)
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCirculation, 114
K. Kyhl, N. Vejlstrup, J. Lønborg, M. Treiman, K. Ahtarovski, S. Helqvist, H. Kelbæk, L. Holmvang, E. Jørgensen, K. Saunamäki, H. Søholm, M. Andersen, J. Møller, P. Clemmensen, T. Engstrøm (2015)
Predictors and prognostic value of left atrial remodelling after acute myocardial infarctionOpen Heart, 2
D. Poci, M. Hartford, T. Karlsson, N. Edvardsson, K. Caidahl (2012)
Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome.The American journal of cardiology, 110 2
G. Batra, B. Svennblad, C. Held, T. Jernberg, P. Johanson, L. Wallentin, J. Oldgren (2016)
All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcomeHeart, 102
I. Eitel, S. Reinstadler, C. Eitel, S. Waha, G. Fuernau, S. Desch, H. Thiele (2016)
Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarctionJournal of Cardiovascular Magnetic Resonance, 18
I. Eitel, J. Wöhrle, Henning Suenkel, J. Meissner, S. Kerber, B. Lauer, M. Pauschinger, R. Birkemeyer, C. Axthelm, R. Zimmermann, P. Neuhaus, O. Brosteanu, S. Waha, S. Desch, M. Gutberlet, G. Schuler, H. Thiele (2013)
Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.Journal of the American College of Cardiology, 61 13
Y. Cha, M. Redfield, W. Shen, B. Gersh (2004)
Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical CycleCirculation: Journal of the American Heart Association, 109
I. Eitel, S. Desch, M. Sareban, G. Fuernau, M. Gutberlet, G. Schuler, H. Thiele (2010)
Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarctionJournal of Cardiovascular Magnetic Resonance, 12
M. Reindl, S. Reinstadler, H. Feistritzer, G. Klug, C. Tiller, J. Mair, A. Mayr, W. Jaschke, B. Metzler (2017)
Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarctionEuropean Heart Journal: Acute Cardiovascular Care, 6
Mohammadali Habibi, J. Lima, I. Khurram, Stefan Zimmerman, V. Zipunnikov, K. Fukumoto, D. Spragg, H. Ashikaga, J. Rickard, J. Marine, H. Calkins, S. Nazarian (2015)
Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.Circulation: Cardiovascular Imaging
J. Somberg, V. Torres, G. Keren, B. Butler, D. Tepper, Herman Kleinbaum, J. Molnar (2004)
Enhancement of Myocardial Vulnerability by Atrial FibrillationAmerican Journal of Therapeutics, 11
M. Alasady, N. Shipp, A. Brooks, Han Lim, D. Lau, D. Barlow, P. Kuklik, M. Worthley, K. Roberts‐Thomson, D. Saint, W. Abhayaratna, P. Sanders (2013)
Myocardial Infarction and Atrial Fibrillation: Importance of Atrial IschemiaCirculation: Arrhythmia and Electrophysiology, 6
Background— Atrial fibrillation (AF) is frequently observed in patients with ST-segment–elevation myocardial infarction and associated with worse clinical outcome. However, the mechanisms for this increased risk are not fully understood. The purpose of this study was to investigate the relationship of the presence of AF to cardiac magnetic resonance (CMR) derived myocardial salvage and damage as well as clinical outcomes. Methods and Results— This multicenter CMR study enrolled 786 patients with ST-segment–elevation myocardial infarction. CMR parameters (infarct size, myocardial salvage index, microvascular obstruction, and myocardial function) were assessed 3 (interquartile range [IQR], 2–4) days post-ST-segment–elevation myocardial infarction and compared between patients with or without AF during hospitalization. Major adverse cardiac events were assessed as a composite of all-cause death, reinfarction, and new congestive heart failure at 12 months. AF was documented in 48 (6.1%) patients. There was no significant difference in infarct size (18 [IQR, 9–29]% versus 17 [IQR, 9–25]% of left ventricular mass; P=0.340), myocardial salvage index (51 [IQR, 34–69] versus 51 [IQR, 33–69]; P=0.830), or microvascular obstruction (0.6 [IQR, 0–2.0]% versus 0.0 [IQR, 0–1.8]% of left ventricular mass; P=0.340) between groups. Patients with AF had significantly lower left ventricular (47 [IQR, 34–54]% versus 51 [IQR, 44–58]%; P=0.003) and left atrial (42 [IQR, 17–57]% versus 53 [IQR, 45–59]%; P<0.001) ejection fraction. AF was associated with major adverse cardiac events, even when adjusting for clinical risk factors (odds ratio, 2.48 [95% confidence interval, 1.22–5.03]; P=0.0120) or CMR prognosis markers (odds ratio, 3.77 [95% confidence interval, 1.83–7.79]; P=0.001). Conclusions— This CMR study found no major differences in myocardial salvage, infarct size, or microvascular damage in patients with ST-segment–elevation myocardial infarction or without AF. AF was, however, associated with cardiac dysfunction and independently related to major adverse cardiac events. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00712101.
Circulation: Cardiovascular Imaging – Wolters Kluwer Health
Published: Feb 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.